Yahoo Web Search

  1. Ads
    related to "multiple sclerosis"
  1. Yahoo Finance Results

  2. WALTHAM, Mass., Oct. 2, 2018 /PRNewswire/ -- Accelerated Cure Project (ACP) for Multiple Sclerosis (MS) today announced it has entered into a ground-breaking collaboration with ...

  3. MNOV: Positive FDA Feedback on ALS Phase 3 Plan…

    Zacks Small Cap Research via Yahoo FinanceSep 28 13:45 PM

    On September 25, 2018, MediciNova, Inc. (MNOV) announced that the FDA provided positive feedback in regards to the company’s development plan for MN-166 (ibudilast) in amyotrophic lateral sclerosis ...

  4. 2 Stocks That Can Safely Double Your Money

    Motley Fool via Yahoo FinanceOct 02 15:00 PM

    The large-cap megapharmas AstraZeneca (NYSE: AZN) and Celgene Corporation (NASDAQ: CELG), for instance, are both slated to produce stellar returns on capital for investors in the next decade ...

  5. The FDA granted approval to Lilly’s LLY calcitonin gene-related peptide ("CGRP") antibody, Emgality (galcanezumab) for migraine and Pfizer’s PFE Vizimpro (dacomitinib) for an advanced lung cancer ...

  6. Novartis Gets Positive CHMP Opinion for Drugs, Biosimilar

    Zacks via Yahoo FinanceSep 24 20:00 PM

    Voretigene neparvovec is marketed as Luxturna in the United States by Spark Therapeutics ONCE. A decision from the European Commission is expected in two...

  7. While regulators warn of the risk of buying drugs online, the Amsterdam-based Social Medwork sees its network of trusted suppliers as filling a gap in the market for the latest drugs against ...

  8. TG Therapeutics (TGTX) in Focus: Stock Moves 8.6% Higher

    Zacks via Yahoo FinanceSep 28 14:05 PM

    TG Therapeutics, Inc. TGTX was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.

  9. Teva Pharmaceutical Stock Wins 2 Upgrades: What You Need to Know

    Motley Fool via Yahoo FinanceOct 01 17:05 PM

    This morning should have been a great one for shareholders of Teva Pharmaceutical Industries (NYSE: TEVA). One a one-two punch of upgrade goodness, Teva won a pair of endorsements from two separate ...

  10. Wednesday was a relatively calm day on Wall Street until the last few minutes of the trading session, as major market benchmarks didn't initially respond in dramatic fashion to much-anticipated ...

  11. Can Biogen Continue to Be a Top Performer in the Biotech Space?

    GuruFocus.com via Yahoo FinanceSep 24 20:06 PM

    BIIB 15-Year Financial Data The intrinsic value of BIIB Peter Lynch Chart of BIIB Apart from the revenues generated from these drugs, Biogen has key partnerships with other large pharmaceutical ...

  1. Ads
    related to "multiple sclerosis"